Aro Biotherapeutics is based in Philadelphia. It has raised $42M in total funding. Latest round: Series B.
Aro Biotherapeutics is based in Philadelphia. Aro Biotherapeutics has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2023. The round record for Aro Biotherapeutics runs through 2023; nothing later has been disclosed. Investors on record include Cowen Healthcare Investments, Johnson & Johnson Innovation – JJDC, Inc., Northpond Ventures, Healthcap, BVF Partners, L.P.. 5 distinct backers are named across the disclosed rounds.
We update the Aro Biotherapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Philadelphia and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026